A groundbreaking study is providing a more complete understanding of how Alzheimer’s disease worsens in the brain, helping to unite what had been two separate schools of thought on the causes of Alzheimer’s, and accelerating future research into effective treatments and cure.
Two scientists at the University of Florida, supported by a grant from BrightFocus’ Macular Degeneration Research program, have uncovered some tantalizing clues that a drug previously investigated to protect against nerve damage during cancer treatment could offer some protection for the nerve cells of the eye in late-stage dry age-related macular degeneration.
Kip Connor, PhD, with funding from Macular Degeneration Research (MDR), has lead a team of experts to discover an important role of immune cells that regulate, and could potentially stop, abnormal blood vessel growth in advanced age-related macular degeneration (AMD).
Our sneak preview of The Crowd & the Cloud, a new PBS series featuring the BrightFocus-funded EyesOnAlz project. Set to air April 6, it’s an epic look at what ordinary citizens are doing to improve health and cure diseases, even Alzheimer’s!